GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Danapha Pharmaceutical JSC (HSTC:DAN) » Definitions » EPS (Basic)

Danapha Pharmaceutical JSC (HSTC:DAN) EPS (Basic) : ₫ (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Danapha Pharmaceutical JSC EPS (Basic)?

Danapha Pharmaceutical JSC's basic earnings per share (Basic EPS) for the six months ended in . 20 was ₫0.00. Danapha Pharmaceutical JSC does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Danapha Pharmaceutical JSC's EPS (Diluted) for the six months ended in . 20 was ₫0.00. Danapha Pharmaceutical JSC does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Danapha Pharmaceutical JSC's EPS without NRI for the six months ended in . 20 was ₫0.00. Danapha Pharmaceutical JSC does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Danapha Pharmaceutical JSC EPS (Basic) Historical Data

The historical data trend for Danapha Pharmaceutical JSC's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Danapha Pharmaceutical JSC EPS (Basic) Chart

Danapha Pharmaceutical JSC Annual Data
Trend
EPS (Basic)

Danapha Pharmaceutical JSC Semi-Annual Data
EPS (Basic)

Danapha Pharmaceutical JSC EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Danapha Pharmaceutical JSC's Basic EPS for the fiscal year that ended in . 20 is calculated as


Danapha Pharmaceutical JSC's Basic EPS for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Danapha Pharmaceutical JSC  (HSTC:DAN) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Danapha Pharmaceutical JSC EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Danapha Pharmaceutical JSC's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Danapha Pharmaceutical JSC Business Description

Traded in Other Exchanges
N/A
Address
253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.